Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer intended for use in high-volume transfusion medicine laboratories. The instrument is now ...
RARITAN, N.J., May 3, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Ortho Clinical Diagnostics announced it ...
QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, will highlight its ongoing commitment to transfusion medicine excellence at the Association for the Advancement of ...
RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...
Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback